Shuttle Pharmaceuticals Holdings, Inc. (SHPH): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$290.1K
Year ended 2025-12-31
$1.56M
Trailing 12 months to 2026-06-30
2024-12-31: $5.5K2025-12-31: $290.1K$290.1K
2024-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$290.1Kn/m2026-03-31, From 2025-01-01
2024-12-31$5.5Kn/a2026-03-31, From 2024-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)2025-12-31$290.1Kn/m
Traws Pharma, Inc. (TRAW)2025-12-31$61.0K+408.3%
Longeveron Inc. (LGVN)2025-12-31$800.0K+14.3%
Lantern Pharma Inc. (LTRN)2025-12-31$17.3K0.0%
Decoy Therapeutics Inc. (DCOY)2025-12-31$7.2K+61.6%
Cocrystal Pharma, Inc. (COCP)2025-12-31$72.0K-42.9%
NewcelX Ltd. (NCEL)2025-12-31$55.0K-86.7%
Can-Fite BioPharma Ltd. (CANF)2025-12-31$24.0K+242.9%
Kala Bio, Inc. (KALA)2025-12-31$317.0K+22.4%

Compare SHPH, TRAW, LGVN, LTRN side by side · Screen every company in Pharmaceutical Preparations ↗